NCT06794593View on ClinicalTrials.gov

Effect Camostat for Kidney Protection in Chronic Kidney Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

February 28, 2027

Conditions
Chronic Kidney Disease(CKD)
Interventions
DRUG

Camostat Mesylate

Oral Camostat Mesylate 200 mg x 3 daily for 4 days.

Trial Locations (1)

5000

RECRUITING

Department of Nephrology, Odense University Hospital, Odense

All Listed Sponsors
lead

Odense University Hospital

OTHER